Health insurance companies are lobbying the Trump administration to reject Biden-era proposals that would expand Medicare and ...

Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t ...

Eli Lilly is offering higher-dose vials through its direct-to-consumer website, LillyDirect, which started offering lower ...

Coverage complications are not unusual in the U.S. healthcare system. But the challenge is magnified for these obesity ...

Hims & Hers Health has blazed a red-hot streak, helped by the growing popularity of weight-loss drugs. But after a massive ...

Unfortunately, Medicare is forbidden to cover weight loss drugs for obesity unless patients possess another medical condition such as diabetes or cardiovascular disease. This policy prevents ...

Medicare does not currently cover weight loss medications, but it may cover Mounjaro for type 2 diabetes. Coverage may depend on your prescription drug plan type, and out-of-pocket costs may apply.

Due to current legislation regarding weight loss drugs, it is not yet available to Medicare recipients. But in November 2024, the Centers for Medicare & Medicaid Services (CMS) proposed ...

Coverage under Medicare remains prohibited while most large employer firms still do not cover GLP-1 drugs for weight loss. From 2019 to 2023, the number of GLP-1 prescriptions increased by more ...

(Reuters) - Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 billion between 2019 and 2023, a U.S. government watchdog's ...

Advocates of the anti-obesity medications are hopeful, especially if the proposed rule lifting the restriction on Medicare coverage of weight loss drugs is enacted. The comment period on the ...